Clinical trial of LMB-100 in patients with mesothelioma.
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 May 2017
Price : $35 *
At a glance
- Drugs LMB 100 (Primary)
- Indications Mesothelioma
- Focus Adverse reactions
- 11 May 2017 New trial record
- 02 May 2017 According to a Selecta Biosciences media release, Center for Cancer Research (CCR) is in the process of completing this trial.